The hematology analyzers and reagents market size has grown marginally in recent years. It will grow from $5.25 billion in 2025 to $5.26 billion in 2026 at a compound annual growth rate (CAGR) of 0.2%. The growth in the historic period can be attributed to increasing prevalence of anemia and blood-related disorders, growing hospital and diagnostic laboratory infrastructure, reliance on manual and semi-automated analyzers, rising demand for complete blood count testing, expansion of clinical diagnostic services.
The hematology analyzers and reagents market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to integration of AI-based cell analysis, rising adoption of fully automated hematology systems, growing focus on precision medicine and personalized diagnostics, expansion of diagnostic centers in emerging markets, increasing demand for advanced reagents and consumables. Major trends in the forecast period include rising adoption of automated and high-throughput hematology analyzers, growing demand for accurate and early diagnosis of blood disorders, increasing use of point-of-care hematology testing, expansion of reagent rental and consumable-based business models, enhanced focus on standardization and quality control in hematology testing.
The rise in the prevalence of blood disorders is increasingly supporting the expansion of the hematology analyzers and reagents market going forward. Blood disorders are medical conditions that impair the normal function of blood components such as red blood cells, white blood cells, or platelets. Hematology analyzers and reagents are essential for diagnosing and monitoring blood disorders, including blood cancers, by evaluating blood cell counts, morphology, and related parameters. For example, in July 2024, according to Cancer Research UK, a UK-based charity, the average annual number of new Hodgkin lymphoma cases in the UK is projected to increase from approximately 2,400 cases during 2023-2025 to around 2,900 cases during 2038-2040. Consequently, the growing prevalence of blood disorders is supporting the expansion of the hematology analyzers and reagents market.
Leading companies operating in the hematology analyzers and reagents market are focusing on developing innovative solutions, such as automated hematology platforms, to improve diagnostic accuracy, streamline laboratory workflows, and deliver more comprehensive patient data. An automated hematology platform is a computer-driven laboratory system designed to perform complete blood counts and related tests quickly and accurately with minimal human involvement. For example, in January 2024, HORIBA Medical, a France-based in vitro diagnostics company, launched Yumizen Helo, a next-generation, fully automated and modular hematology solution. The system integrates a high-throughput analyzer, digital cell morphology, and automated reticulocyte analysis into a single compact unit. Its walkaway automation uses an intelligent robotic arm to prepare and sort blood smears automatically, reducing manual steps and improving productivity by consolidating multiple hematology tasks into one continuous workflow.
In January 2024, Fujirebio Holdings, a Japan-based diagnostics company, entered into a partnership with Agappe Diagnostics Ltd. Through this partnership, the companies aim to collaborate on the development of advanced diagnostic technologies and expand their product offerings within the global healthcare market. Agappe Diagnostics Ltd. is an India-based diagnostics company specializing in the development and manufacture of a wide range of innovative diagnostic solutions.
Major companies operating in the hematology analyzers and reagents market are Abbott Laboratories, Bio-Rad Laboratories, Horiba Ltd., Siemens AG, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd, Boule Diagnostics, Danaher Corporation, Diatron MI PLC, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer AG, Heska, Drucker, Instrumentation Laboratory, Abaxis Inc., Accriva Diagnostics, ACON, Diamond Diagnostics, ERBA Diagnostics, Hycel, Maccura Biotechnology Co. Ltd., Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS.
North America was the largest region in the hematology analyzers and reagents market in 2025. Western Europe was the second-largest region in the hematology analyzers and reagents market report. The regions covered in the hematology analyzers and reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hematology analyzers and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hematology analyzers and reagents market by increasing costs for imported analyzers, electronic components, and specialized reagents used in diagnostic testing. Segments such as automated hematology analyzers, flow cytometers, and coagulation analyzers are most affected, particularly in Asia-Pacific and emerging regions that depend on imported diagnostic equipment. These cost pressures have led to higher pricing and delayed procurement for hospitals and laboratories. However, tariffs have also encouraged local manufacturing, reagent localization, and partnerships to reduce dependency on imports and strengthen regional diagnostic capabilities.
The hematology analyzers and reagents market research report is one of a series of new reports that provides hematology analyzers and reagents market statistics, including hematology analyzers and reagents industry global market size, regional shares, competitors with a hematology analyzers and reagents market share, detailed hematology analyzers and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the hematology analyzers and reagents industry. This hematology analyzers and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hematology analyzers perform complete blood counts with white blood cell differentials, detect abnormal cell populations, and assess cell morphology to help diagnose various blood disorders.
The primary products in hematology analyzers and reagents include hematology analyzers, hemostasis analyzers, plasma protein analyzers, hemoglobin analyzers, erythrocyte sedimentation rate analyzers, coagulation analyzers, flow cytometers, slide stainers, differential counters, and hematology stains. Hematology analyzers are instruments used to determine hemoglobin concentration in blood samples. The applications include anemia, blood cancers, hemorrhagic disorders, infection-related conditions, immune system-related diseases, and others, and they are used by end users such as specialized research institutes, hospitals, advanced diagnostic centers, and others.
The hematology analyzers and reagents market consists of sales electrolyte analyzers, hemocoagulometer, enzyme standard instruments, blood gas analyzers and immunoturbidimetry. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hematology analyzers and reagents market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to integration of AI-based cell analysis, rising adoption of fully automated hematology systems, growing focus on precision medicine and personalized diagnostics, expansion of diagnostic centers in emerging markets, increasing demand for advanced reagents and consumables. Major trends in the forecast period include rising adoption of automated and high-throughput hematology analyzers, growing demand for accurate and early diagnosis of blood disorders, increasing use of point-of-care hematology testing, expansion of reagent rental and consumable-based business models, enhanced focus on standardization and quality control in hematology testing.
The rise in the prevalence of blood disorders is increasingly supporting the expansion of the hematology analyzers and reagents market going forward. Blood disorders are medical conditions that impair the normal function of blood components such as red blood cells, white blood cells, or platelets. Hematology analyzers and reagents are essential for diagnosing and monitoring blood disorders, including blood cancers, by evaluating blood cell counts, morphology, and related parameters. For example, in July 2024, according to Cancer Research UK, a UK-based charity, the average annual number of new Hodgkin lymphoma cases in the UK is projected to increase from approximately 2,400 cases during 2023-2025 to around 2,900 cases during 2038-2040. Consequently, the growing prevalence of blood disorders is supporting the expansion of the hematology analyzers and reagents market.
Leading companies operating in the hematology analyzers and reagents market are focusing on developing innovative solutions, such as automated hematology platforms, to improve diagnostic accuracy, streamline laboratory workflows, and deliver more comprehensive patient data. An automated hematology platform is a computer-driven laboratory system designed to perform complete blood counts and related tests quickly and accurately with minimal human involvement. For example, in January 2024, HORIBA Medical, a France-based in vitro diagnostics company, launched Yumizen Helo, a next-generation, fully automated and modular hematology solution. The system integrates a high-throughput analyzer, digital cell morphology, and automated reticulocyte analysis into a single compact unit. Its walkaway automation uses an intelligent robotic arm to prepare and sort blood smears automatically, reducing manual steps and improving productivity by consolidating multiple hematology tasks into one continuous workflow.
In January 2024, Fujirebio Holdings, a Japan-based diagnostics company, entered into a partnership with Agappe Diagnostics Ltd. Through this partnership, the companies aim to collaborate on the development of advanced diagnostic technologies and expand their product offerings within the global healthcare market. Agappe Diagnostics Ltd. is an India-based diagnostics company specializing in the development and manufacture of a wide range of innovative diagnostic solutions.
Major companies operating in the hematology analyzers and reagents market are Abbott Laboratories, Bio-Rad Laboratories, Horiba Ltd., Siemens AG, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd, Boule Diagnostics, Danaher Corporation, Diatron MI PLC, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer AG, Heska, Drucker, Instrumentation Laboratory, Abaxis Inc., Accriva Diagnostics, ACON, Diamond Diagnostics, ERBA Diagnostics, Hycel, Maccura Biotechnology Co. Ltd., Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS.
North America was the largest region in the hematology analyzers and reagents market in 2025. Western Europe was the second-largest region in the hematology analyzers and reagents market report. The regions covered in the hematology analyzers and reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hematology analyzers and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hematology analyzers and reagents market by increasing costs for imported analyzers, electronic components, and specialized reagents used in diagnostic testing. Segments such as automated hematology analyzers, flow cytometers, and coagulation analyzers are most affected, particularly in Asia-Pacific and emerging regions that depend on imported diagnostic equipment. These cost pressures have led to higher pricing and delayed procurement for hospitals and laboratories. However, tariffs have also encouraged local manufacturing, reagent localization, and partnerships to reduce dependency on imports and strengthen regional diagnostic capabilities.
The hematology analyzers and reagents market research report is one of a series of new reports that provides hematology analyzers and reagents market statistics, including hematology analyzers and reagents industry global market size, regional shares, competitors with a hematology analyzers and reagents market share, detailed hematology analyzers and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the hematology analyzers and reagents industry. This hematology analyzers and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hematology analyzers perform complete blood counts with white blood cell differentials, detect abnormal cell populations, and assess cell morphology to help diagnose various blood disorders.
The primary products in hematology analyzers and reagents include hematology analyzers, hemostasis analyzers, plasma protein analyzers, hemoglobin analyzers, erythrocyte sedimentation rate analyzers, coagulation analyzers, flow cytometers, slide stainers, differential counters, and hematology stains. Hematology analyzers are instruments used to determine hemoglobin concentration in blood samples. The applications include anemia, blood cancers, hemorrhagic disorders, infection-related conditions, immune system-related diseases, and others, and they are used by end users such as specialized research institutes, hospitals, advanced diagnostic centers, and others.
The hematology analyzers and reagents market consists of sales electrolyte analyzers, hemocoagulometer, enzyme standard instruments, blood gas analyzers and immunoturbidimetry. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hematology Analyzers and Reagents Market Characteristics
3. Hematology Analyzers and Reagents Market Supply Chain Analysis
4. Global Hematology Analyzers and Reagents Market Trends and Strategies
5. Hematology Analyzers and Reagents Market Analysis of End Use Industries
7. Global Hematology Analyzers and Reagents Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hematology Analyzers and Reagents Total Addressable Market (TAM) Analysis for the Market
9. Hematology Analyzers and Reagents Market Segmentation
10. Hematology Analyzers and Reagents Market Regional and Country Analysis
11. Asia-Pacific Hematology Analyzers and Reagents Market
12. China Hematology Analyzers and Reagents Market
13. India Hematology Analyzers and Reagents Market
14. Japan Hematology Analyzers and Reagents Market
15. Australia Hematology Analyzers and Reagents Market
16. Indonesia Hematology Analyzers and Reagents Market
17. South Korea Hematology Analyzers and Reagents Market
18. Taiwan Hematology Analyzers and Reagents Market
19. South East Asia Hematology Analyzers and Reagents Market
20. Western Europe Hematology Analyzers and Reagents Market
21. UK Hematology Analyzers and Reagents Market
22. Germany Hematology Analyzers and Reagents Market
23. France Hematology Analyzers and Reagents Market
24. Italy Hematology Analyzers and Reagents Market
25. Spain Hematology Analyzers and Reagents Market
26. Eastern Europe Hematology Analyzers and Reagents Market
27. Russia Hematology Analyzers and Reagents Market
28. North America Hematology Analyzers and Reagents Market
29. USA Hematology Analyzers and Reagents Market
30. Canada Hematology Analyzers and Reagents Market
31. South America Hematology Analyzers and Reagents Market
32. Brazil Hematology Analyzers and Reagents Market
33. Middle East Hematology Analyzers and Reagents Market
34. Africa Hematology Analyzers and Reagents Market
36. Hematology Analyzers and Reagents Market Competitive Landscape and Company Profiles
37. Hematology Analyzers and Reagents Market Other Major and Innovative Companies
40. Hematology Analyzers and Reagents Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hematology Analyzers and Reagents Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hematology analyzers and reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hematology analyzers and reagents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hematology analyzers and reagents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Hematology Analyzers; Hemostasis Analyzers; Plasma Protein Analyzers; Hemoglobin Analyzers; Erythrocyte Sedimentation Rate Analyzer; Coagulation Analyzer2) By Applications: Anemias; Blood Cancers; Hemorrhagic Conditions; Infection Related Conditions; Immune System Related Conditions; Other Applications
3) By End User: Specialized Research Institutes; Hospitals; Specialized Diagnostic Centers; Other End Users
Subsegments:
1) By Hematology Analyzers: Automated Hematology Analyzers; Semi-Automated Hematology Analyzers2) By Hemostasis Analyzers: Platelet Function Analyzers; Coagulation Testing Analyzers
3) By Plasma Protein Analyzers: Electrophoresis Analyzers; Immunofixation Analyzers
4) By Hemoglobin Analyzers: Point-Of-Care Hemoglobin Analyzers; Laboratory Hemoglobin Analyzers
5) By Erythrocyte Sedimentation Rate Analyzer: Manual ESR Analyzers; Automated ESR Analyzers
6) By Coagulation Analyzer: Clotting Time Analyzers; Thromboelastography (TEG) Analyzers
Companies Mentioned: Abbott Laboratories; Bio-Rad Laboratories; Horiba Ltd.; Siemens AG; Sysmex Corporation; BioSystems Diagnostics Pvt. Ltd; Boule Diagnostics; Danaher Corporation; Diatron MI PLC; Drew Scientific; EKF Diagnostics; Mindray; Nihon Kohden; Ortho Clinical Diagnostics; Roche; Beckman Coulter; Bayer AG; Heska; Drucker; Instrumentation Laboratory; Abaxis Inc.; Accriva Diagnostics; ACON; Diamond Diagnostics; ERBA Diagnostics; Hycel; Maccura Biotechnology Co. Ltd.; Genrui Biotech Inc.; A&T Corporation; Beijing Succeeder Technology Inc.; Diagnostica Stago SAS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hematology Analyzers and Reagents market report include:- Abbott Laboratories
- Bio-Rad Laboratories
- Horiba Ltd.
- Siemens AG
- Sysmex Corporation
- BioSystems Diagnostics Pvt. Ltd
- Boule Diagnostics
- Danaher Corporation
- Diatron MI PLC
- Drew Scientific
- EKF Diagnostics
- Mindray
- Nihon Kohden
- Ortho Clinical Diagnostics
- Roche
- Beckman Coulter
- Bayer AG
- Heska
- Drucker
- Instrumentation Laboratory
- Abaxis Inc.
- Accriva Diagnostics
- ACON
- Diamond Diagnostics
- ERBA Diagnostics
- Hycel
- Maccura Biotechnology Co. Ltd.
- Genrui Biotech Inc.
- A&T Corporation
- Beijing Succeeder Technology Inc.
- Diagnostica Stago SAS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.26 Billion |
| Forecasted Market Value ( USD | $ 7.19 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
